Innovating Works

IBERCENTRO MEDIA CONSULTING Y SERVICES

Activa
Lakhesys: Lakhesys building the machine to make the medicines of tomorrow ASTRAVEUS SAS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Chimeric Antigen Receptor T-cell therapies (‘CAR-T’) are ushering in an incredibly exciting era of using a patient’s own cells to cure their...
2019-02-28 - 2023-02-28 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.